옵션 체인은 다양한 행사가격과 만기일에 대한 AmpliTech Group의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 AmpliTech Group에 대한 시장 심리를 평가합니다..

AmpliTech Group (NASDAQ:AMPG) 주식, 옵션 체인

AmpliTech Gr

AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.

AmpliTech Group Inc

DA Davidson analyst Gil Luria maintains NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) with a Neutral and maintains $120 price target.

News

Price Target

Analyst Ratings

NVDA

DA Davidson Maintains Neutral on NVIDIA, Maintains $120 Price Target

<ul>
<li>Gloperba&#xAE; is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.</li>
<li>Pericarditis is an inflammation of the pericardium, the sac-like membrane that surrounds and protects the heart. It occurs when the pericardium becomes irritated or infected, leading to swelling and pain.</li>
</ul>
PALO ALTO, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCLX#NASDAQ">SCLX</a>, "Scilex" or "Company"))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, following the formation of its proposed joint venture with IPMC Company, neurodegenerative and cardiometabolic disease, today announced that FDA has approved our request for the Orphan drug designation for colchicine for the treatment of pericarditis.
Gloperba&#xAE; is taken orally like cough syrup. The dosage of 0.6mg per 5ml (teaspoon) can fill that important void in treatment where patients may have difficulty swallowing pills. It can also provide more adjustable dosing, titration and dose-reduction options in specific populations, especially for gout patients with renal or hepatic impairment and reduce side effects with the goal to improve patient convenience and disease management.
Under the Orphan Drug Act, the FDA may grant orphan designation to a drug or biological product intended to treat a rare disease or condition, which is generally a disease or condition that affects fewer than 200,000 individuals in the United States, or more than 200,000 individuals in the United States and for which there is no reasonable expectation that the cost of developing and making the product available in the United States for this type of disease or condition will be recovered from sales of the product. Orphan drug designation must be requested before submitting an NDA. After the FDA grants orphan drug designation, the identity of the therapeutic agent and its potential orphan use are disclosed publicly by the FDA. Orphan drug designation does not convey any advantage in or shorten the duration of the regulatory review and approval process. If a product that has orphan drug designation subsequently receives the first FDA approval for the disease or condition for which it has such designation, the product is entitled to orphan drug exclusivity, which means that the FDA may not approve any other applications to market the same drug for the same indication for seven years from the date of such approval, except in limited circumstances, such as a showing of clinical superiority to the product with orphan exclusivity by means of greater effectiveness, greater safety or providing a major contribution to patient care or in instances of drug supply issues.

SCLX

Scilex Holding Says FDA Approved Request For Orphan Drug Designation For Colchicine For Treatment Of Pericarditis

Stephens &amp; Co. analyst Justin Long reiterated an <a href="https://www.benzinga.com/quote/JBHT/analyst-ratings">Overweight rating </a>on the shares of J B Hunt Transport Services Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) and lowered the price forecast from $170.00 to $165.00.
JBHT posted <a href="https://www.benzinga.com/news/guidance/25/04/44827812/jb-hunt-q1-earnings-revenue-beat-eps-miss-shares-skid">first-quarter FY25 earnings per share</a> of $1.17, topping both internal and consensus forecasts. 
The upside was largely due to stronger intermodal revenue, reduced losses in its Integrated Capacity Solutions (ICS) unit, and lower tax and interest costs, said the analyst.
J.B. Hunt's Intermodal (JBI) segment outperformed expectations, with volumes rising 7.6% year-over-year and contributing $0.07 in EPS upside, driven by strong growth in the Eastern network. 
Also Read: <a href="https://www.benzinga.com/25/04/44825498/bofa-downgrades-pepsico-as-analyst-sees-limited-potential-until-2026">PepsiCo Still A Buy? Not Anymore As Analysts &#8216;Run Out Of Answers&#8217;</a>
The Dedicated segment slightly beat revenue and margin estimates, adding $0.01 to EPS. 
However, weaker Final Mile Services (FMS) and Truckload (JBT) performance weighed on results. Intermodal volumes declined more than seasonal norms but still outperformed expectations. 
Final Mile revenue met projections, but weaker margins resulted in a $0.04 EPS hit. Brokerage missed revenue estimates but narrowed losses, adding $0.04 to EPS. Truckload revenue came in slightly light, and lower margins led to a $0.03 EPS shortfall.
The company continues to reduce ICS expenses and could achieve profitability in that segment this year. JBHT repurchased about 1% of its shares and maintains a focus on shareholder returns.
Price Action: JBHT shares traded lower by 8.47% at $123.68 at last check on Wednesday.
Read Next: <a href="https://www.benzinga.com/25/04/44822504/microsoft-to-back-worlds-largest-co2-removal-project">Microsoft To Back World&#8217;s Largest CO2 Removal Project Worth About $800 Million</a>
Photo: Shutterstock

Reiteration

General

JBHT

Intermodal Strength Drives J B Hunt Transport's Q1 Beat, Says Analyst

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Federal Reserve

Markets

$BTC

Powell Says Stablecoins Could Have A Fairly Wide Appeal And Should Contain Consumer Protections

DA Davidson analyst Manuel Navas maintains Fulton Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FULT#NASDAQ">FULT</a>) with a Neutral and maintains $20 price target.

FULT

DA Davidson Maintains Neutral on Fulton Financial, Maintains $20 Price Target

Macro Economic Events

Global

Economics

Fed Chair Powell Says U.S. Financial System Is Well Into The Process Of Working Out Its Problems With CRE; Private Credit Market Has Not Been Through A Real Credit Event; Fed Is Keeping A Close Eye On; We Should Proceed To Complete Basel 3 Accord

WIIM

Conduit Pharmaceuticals shares are trading lower. The company announced the appointment of a new CEO.

DA Davidson analyst Michael Baker maintains Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) with a Buy and maintains $415 price target.

ULTA

DA Davidson Maintains Buy on Ulta Beauty, Maintains $415 Price Target

LVTX

LAVA Therapeutics shares are trading higher after the company announced it received a $5.1 million payment obligation waiver.

JFB Construction shares are trading higher after the company announced it was awarded a $21 million multi-family development contract.

DA Davidson analyst Michael Baker maintains Lowe's Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>) with a Neutral and maintains $270 price target.

DA Davidson Maintains Neutral on Lowe's Companies, Maintains $270 Price Target

Chinese electric vehicle company&nbsp;XPeng Inc &#8211; ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) rolled out an ambitious strategy <a href="https://www.benzinga.com/topic/artificial-intelligence">blending artificial intelligence</a>, robotics and advanced energy solutions.
The company unveiled its latest initiatives, including the <a href="https://www.benzinga.com/pressreleases/25/04/g44822955/xpeng-unveils-ai-tech-tree-strategy-upgrade-to-reshape-future-mobility-launches-2025-flagship-x9">global debut of its 2025 XPENG X9 model </a>and a roadmap that connects smart EVs, flying cars and humanoid robots under its AI Tech Tree platform.
XPeng is placing artificial intelligence at the heart of its tech-driven growth, integrating custom-built large-scale AI models and specialized chips to drive its next-generation vehicles and advanced innovations.
XPeng&#8217;s homegrown Turing AI chip, featuring a 40-core processor capable of processing 30-billion-parameter models, is scheduled for mass production in mainland China by mid-2025. 
Also Read: <a href="https://www.benzinga.com/news/global/25/04/44820082/global-electric-vehicle-sales-jump-in-march-what-country-leads-in-sales">Global Electric Vehicle Sales Jump In March: What Country Leads In Sales?</a>
This chip underpins multiple products, including autonomous vehicles and robotic platforms.
One of the automaker&#8217;s most forward-looking projects, the AEROHT Land Aircraft Carrier, a modular flying vehicle is scheduled to enter production in 2026, with more than 4,000 pre-orders already secured. 
The company also unveiled "IRON," a humanoid robot equipped with 60 articulating joints, a 200-degree range of motion and a 720-degree AI-enabled vision system.
XPeng debuted the X9 model, which includes nearly 500 upgrades, such as ultra-fast 800V charging, zero-gravity seating, and an AI-tuned adaptive suspension system.
With XPeng's Turing Smart Driving suite standard on all trims, the vehicle enables full point-to-point autonomous driving. Its battery system allows 405 kilometers of range in a 10-minute charge and achieves 80% capacity in just 12 minutes.
In response to gaps in global charging availability, XPeng is preparing its Kunpeng Super Electric System for mass rollout by late 2025. The platform will boost electric-only range to 430 km and hybrid range to 1,400 km, aimed at enhancing convenience and adaptability in international markets.
The EV maker <a href="https://www.benzinga.com/trading-ideas/movers/25/04/44582215/chinas-xpeng-clocks-record-q1-ev-sales-deliveries-surge-3-6x">delivered 94,008 Smart EVs in the first quarter</a>, a 331% increase over last year.
XPEV Price Action: XPEV shares traded lower by 6.21% at $18.58 in publication Wednesday.
Read Next: • <a href="https://www.benzinga.com/25/04/44825498/bofa-downgrades-pepsico-as-analyst-sees-limited-potential-until-2026">PepsiCo Still A Buy? Not Anymore As Analysts &#8216;Run Out Of Answers&#8217;</a> Photo: <a href="https://www.shutterstock.com/g/THINK+B">THINK A</a> via Shutterstock

XPEV

Tesla Rival XPeng Unveils Bold Vision: AI-Powered EVs, Flying Cars, Humanoid Robots

Powell Says We Stand Ready To Supply Dollars To Global Central Banks If Needed

RIME

Algorhythm Holdings shares are trading lower after the company reported a year-over-year decrease in FY24 financial results.

Over the next three to five years, Google&#8217;s primary upside valuation driver will be its proprietary <a href="https://www.benzinga.com/topic/artificial-intelligence">large language models (LLMs)</a>. 
That&#8217;s according to Needham analyst Laura Martin, who reiterated Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), Google&#8217;s parent company, with a Buy and a $178 price target on Wednesday.
She expects GenAI to aid Google&#8217;s internal operations and increase revenue growth. Martin adds that Google Cloud will generate revenue from both LLMs and the applications built upon them.
Also Read: <a href="https://www.benzinga.com/25/04/44765778/google-takes-on-microsoft-with-ai-powered-workspace-2-billion-savings-deal-for-us-agencies" target="_blank" rel="noreferrer noopener">Google Undercuts Microsoft With Massive Discount for Government, Expands AI-Powered Workspace Offerings</a>
GenAI&#8217;s LLMs must be fed millions of data points every day. Google&#8217;s search engine and YouTube platform give the Gemini LLM competitive advantages and a deep moat, she says. 
Ultimately, GenAI will disrupt content creation, user behavior, and business models.
What&#8217;s Next: On May 8, as part of the 20th annual Needham Internet &amp; Media conference, Martin will host a virtual Zoom panel entitled &#8220;The Impact of GenAI on Media &amp; Internet.&#8221;&nbsp;&nbsp;
One panel is expected to discuss various stocks, including Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), GOOGL, Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), The Trade Desk, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>), Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>), Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>), Reddit, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>), Roku, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>).
As for Google&#8217;s &#8220;Zero Click&#8221; strategy, it was GenAI&#8217;s most significant 2024 disruption, Martin says. She will focus on the key valuation dislocations, including:
<ul>
<li>The possibility of GenAI eroding the foundations of digital advertising</li>
<li>The positives of expanding margins from GenAI offset by falling barriers to entry for new competitors</li>
<li>And whether the proliferation of GenAI-related content is good for any incumbent.</li>
</ul>
As the internet is flooded with new cheap, low-value content, Martin seeks to know whether this will affect consumer trust, reduce session time, and hurt monetization for higher-quality online content.
As GenAI summaries in search results eliminate the need to click through to links, this is lowering ad monetization for publishers that have historically relied on traffic referrals. Therefore, the analyst seeks potential fixes from the aforementioned companies.
After all, media is built on IP, and GenAI increases the risks of copyright violations, hallucinations, and deepfakes. 
Price Action: GOOGL stock is down 1.03% at $154.77 at last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/media/25/04/44768806/use-ai-responsibly-it-should-serve-humanity-not-replace-it-alibabas-jack-ma" target="_blank" rel="noreferrer noopener">Use AI Responsibly, It Should Serve Humanity, Not Replace It: Alibaba&#8217;s Jack Ma</a></li>
</ul>
Image: Shutterstock

Tech

Trading Ideas

AMZN

GOOGL

NFLX

RDDT

ROKU

Google GenAI, AI Cloud Services Drive Analyst Confidence In Long-Term Growth

XTIA

XTI Aerospace shares are trading lower. The company provided 2024 business and progress updates.

Ratings for Vertex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERX#NASDAQ">VERX</a>) were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $51.3, a high estimate of $61.00, and a low estimate of $31.00. A 14.64% drop is evident in the current average compared to the previous average price target of $60.10. 
<img src="https://www.benzinga.com/files/images/story/2025/1744826521_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The perception of Vertex by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;------------------------&#x7C;---------------&#x7C;-----------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Stan Zlotsky &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Overweight &#x7C; $55.00&#x7C;$60.00 &#x7C; 
&#x7C;William Jellison &#x7C;DA Davidson &#x7C;Lowers &#x7C;Buy &#x7C; $50.00&#x7C;$55.00 &#x7C; 
&#x7C;Patrick Walravens &#x7C;Citizens Capital Markets&#x7C;Maintains &#x7C;Market Outperform&#x7C; $61.00&#x7C;$61.00 &#x7C; 
&#x7C;Stan Zlotsky &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Overweight &#x7C; $60.00&#x7C;$57.00 &#x7C; 
&#x7C;Joshua Reilly &#x7C;Needham &#x7C;Maintains &#x7C;Buy &#x7C; $60.00&#x7C;$60.00 &#x7C; 
&#x7C;Adam Hotchkiss &#x7C;Goldman Sachs &#x7C;Lowers &#x7C;Buy &#x7C; $48.00&#x7C;$64.00 &#x7C; 
&#x7C;Samad Samana &#x7C;Jefferies &#x7C;Lowers &#x7C;Buy &#x7C; $48.00&#x7C;$62.00 &#x7C; 
&#x7C;William Jellison &#x7C;DA Davidson &#x7C;Lowers &#x7C;Buy &#x7C; $55.00&#x7C;$62.00 &#x7C; 
&#x7C;Rob Oliver &#x7C;Baird &#x7C;Lowers &#x7C;Outperform &#x7C; $45.00&#x7C;$62.00 &#x7C; 
&#x7C;Brad Reback &#x7C;Stifel &#x7C;Lowers &#x7C;Hold &#x7C; $31.00&#x7C;$58.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Vertex. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Vertex compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Vertex's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Vertex's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/VERX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Vertex analyst ratings.</a>
<h2>Delving into Vertex's Background</h2>
Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. Vertex provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting among others. The company derives revenue from software subscriptions.
<h3>Vertex's Financial Performance</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Vertex displayed positive results in 3M. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 15.2%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Vertex's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -37.99%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Vertex's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -30.93%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Vertex's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -5.75%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Vertex's debt-to-equity ratio stands notably higher than the industry average, reaching 1.96. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>The Basics of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VERX

Analyst Expectations For Vertex's Future

Throughout the last three months, 8 analysts have evaluated Allison Transmission (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALSN#NYSE">ALSN</a>), offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $103.75, a high estimate of $115.00, and a low estimate of $94.00. This current average represents a 10.94% decrease from the previous average price target of $116.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1744826514_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A comprehensive examination of how financial experts perceive Allison Transmission is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Angel Castillo &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $94.00&#x7C;$112.00 &#x7C; 
&#x7C;Luke Junk &#x7C;Baird &#x7C;Lowers &#x7C;Neutral &#x7C; $100.00&#x7C;$123.00 &#x7C; 
&#x7C;Tim Thein &#x7C;Raymond James &#x7C;Lowers &#x7C;Outperform &#x7C; $110.00&#x7C;$115.00 &#x7C; 
&#x7C;Tami Zakaria &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $98.00&#x7C;$110.00 &#x7C; 
&#x7C;Kyle Menges &#x7C;Citigroup &#x7C;Lowers &#x7C;Neutral &#x7C; $95.00&#x7C;$108.00 &#x7C; 
&#x7C;Kyle Menges &#x7C;Citigroup &#x7C;Lowers &#x7C;Neutral &#x7C; $108.00&#x7C;$115.00 &#x7C; 
&#x7C;Tami Zakaria &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $110.00&#x7C;$129.00 &#x7C; 
&#x7C;Kyle Menges &#x7C;Citigroup &#x7C;Lowers &#x7C;Neutral &#x7C; $115.00&#x7C;$120.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Allison Transmission. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Allison Transmission compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Allison Transmission's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Allison Transmission's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/ALSN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Allison Transmission analyst ratings.</a>
<h2>Discovering Allison Transmission: A Closer Look</h2>
Allison Transmission is the largest manufacturer of fully automatic transmissions for commercial vehicles. The company's automatic transmissions allow customers to achieve better fuel and operator efficiency than less expensive manual and automated manual transmissions. Allison serves several end markets, including on- and off-highway equipment and military vehicles. Its on-highway business has about 60% global market share. The company's transmissions can be found in Class 4-8 trucks, buses, and a limited number of large passenger vehicles (heavy-duty pickup trucks and motor homes). Allison also produces electric hybrid propulsion systems and is developing e-powertrains.
<h3>Allison Transmission: Delving into Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Allison Transmission's remarkable performance in 3M is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 2.71%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Industrials sector.
Net Margin: Allison Transmission's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 21.98% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Allison Transmission's ROE stands out, surpassing industry averages. With an impressive ROE of 10.7%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Allison Transmission's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.27% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Allison Transmission's debt-to-equity ratio stands notably higher than the industry average, reaching 1.46. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALSN

8 Analysts Assess Allison Transmission: What You Need To Know

In the preceding three months, 11 analysts have released ratings for Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), presenting a wide array of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $255.73, a high estimate of $300.00, and a low estimate of $210.00. Marking an increase of 1.15%, the current average surpasses the previous average price target of $252.82. 
<img src="https://www.benzinga.com/files/images/story/2025/1744826505_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The analysis of recent analyst actions sheds light on the perception of Broadcom by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Vivek Arya &#x7C;B of A Securities &#x7C;Lowers &#x7C;Buy &#x7C; $240.00&#x7C;$260.00 &#x7C; 
&#x7C;Christopher Danely &#x7C;Citigroup &#x7C;Lowers &#x7C;Buy &#x7C; $210.00&#x7C;$220.00 &#x7C; 
&#x7C;Joseph Moore &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Overweight &#x7C; $260.00&#x7C;$246.00 &#x7C; 
&#x7C;William Stein &#x7C;Truist Securities &#x7C;Raises &#x7C;Buy &#x7C; $267.00&#x7C;$260.00 &#x7C; 
&#x7C;Matthew Prisco &#x7C;Cantor Fitzgerald &#x7C;Maintains &#x7C;Overweight &#x7C; $300.00&#x7C;$300.00 &#x7C; 
&#x7C;Vijay Rakesh &#x7C;Mizuho &#x7C;Lowers &#x7C;Outperform &#x7C; $250.00&#x7C;$260.00 &#x7C; 
&#x7C;John Vinh &#x7C;Keybanc &#x7C;Raises &#x7C;Overweight &#x7C; $275.00&#x7C;$260.00 &#x7C; 
&#x7C;Cody Acree &#x7C;Benchmark &#x7C;Maintains &#x7C;Buy &#x7C; $255.00&#x7C;$255.00 &#x7C; 
&#x7C;Hans Mosesmann &#x7C;Rosenblatt &#x7C;Maintains &#x7C;Buy &#x7C; $250.00&#x7C;$250.00 &#x7C; 
&#x7C;Joseph Moore &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Overweight &#x7C; $246.00&#x7C;$265.00 &#x7C; 
&#x7C;Tom O'Malley &#x7C;Barclays &#x7C;Raises &#x7C;Overweight &#x7C; $260.00&#x7C;$205.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Broadcom. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Broadcom compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Broadcom's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Broadcom's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/AVGO/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Broadcom analyst ratings.</a>
<h2>Unveiling the Story Behind Broadcom</h2>
Broadcom is the sixth-largest semiconductor company globally and has expanded into various software businesses, with over $30 billion in annual revenue. It sells 17 core semiconductor product lines across wireless, networking, broadband, storage, and industrial markets. It is primarily a fabless designer but holds some manufacturing in-house, like for its best-of-breed FBAR filters that sell into the Apple iPhone. In software, it sells virtualization, infrastructure, and security software to large enterprises, financial institutions, and governments.Broadcom is the product of consolidation. Its businesses are an amalgamation of former companies like legacy Broadcom and Avago Technologies in chips, as well as Brocade, CA Technologies, and Symantec in software.
<h3>A Deep Dive into Broadcom's Financials</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Over the 3M period, Broadcom showcased positive performance, achieving a revenue growth rate of 24.71% as of 31 January, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 36.89%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Broadcom's ROE excels beyond industry benchmarks, reaching 8.01%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Broadcom's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 3.33%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Broadcom's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.95, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>What Are Analyst Ratings?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AVGO

Beyond The Numbers: 11 Analysts Discuss Broadcom Stock

Whales with a lot of money to spend have taken a noticeably bearish stance on Interactive Brokers Group.
Looking at options history for Interactive Brokers Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NASDAQ">IBKR</a>) we detected 17 trades.
If we consider the specifics of each trade, it is accurate to state that 23% of the investors opened trades with bullish expectations and 47% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $295,958 and 11, calls, for a total amount of $507,652.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $100.0 to $195.0 for Interactive Brokers Group over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Interactive Brokers Group's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Interactive Brokers Group's significant trades, within a strike price range of $100.0 to $195.0, over the past month.
<h3>Interactive Brokers Group Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744826504_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>IBKR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$15.3</td>
<td>$13.3</td>
<td>$13.3</td>
<td>$185.00</td>
<td>$93.1K</td>
<td>208</td>
<td align="right">70</td>
</tr>
<tr>
<td>IBKR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$14.4</td>
<td>$13.6</td>
<td>$13.6</td>
<td>$170.00</td>
<td>$82.9K</td>
<td>1.2K</td>
<td align="right">358</td>
</tr>
<tr>
<td>IBKR</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$15.9</td>
<td>$14.6</td>
<td>$15.35</td>
<td>$145.00</td>
<td>$73.6K</td>
<td>45</td>
<td align="right">127</td>
</tr>
<tr>
<td>IBKR</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$59.8</td>
<td>$58.2</td>
<td>$59.0</td>
<td>$105.00</td>
<td>$59.0K</td>
<td>81</td>
<td align="right">15</td>
</tr>
<tr>
<td>IBKR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$26.1</td>
<td>$24.0</td>
<td>$26.1</td>
<td>$140.00</td>
<td>$57.4K</td>
<td>69</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About Interactive Brokers Group</h3>
Interactive Brokers is an online brokerage that generates trading commissions (around 31% of net revenue) from facilitating trading in a wide range of products, including equity, options, futures, foreign exchange, bonds, mutual funds, and exchange-traded funds. Interactive Brokers also generates net interest income (about 64% of net revenue) from idle client cash and earns fees (about 6% of net revenue) from ancillary services. Principal trading and other miscellaneous activities are small (about 5% of net revenue). The firm derives about 70% of its net revenue from the US and 30% from international markets.
In light of the recent options history for Interactive Brokers Group, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Interactive Brokers Group</h3>
<ul>
<li>Trading volume stands at 4,618,067, with IBKR's price down by -11.43%, positioned at $153.61.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 90 days.</li>
</ul>
<h3>Professional Analyst Ratings for Interactive Brokers Group</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $206.2.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on Interactive Brokers Group with a target price of $192. 
&#x2A; An analyst from Barclays has decided to maintain their Overweight rating on Interactive Brokers Group, which currently sits at a price target of $193. 
&#x2A; An analyst from Barclays has decided to maintain their Overweight rating on Interactive Brokers Group, which currently sits at a price target of $188. 
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on Interactive Brokers Group with a target price of $243. 
&#x2A; An analyst from Citigroup persists with their Buy rating on Interactive Brokers Group, maintaining a target price of $215. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Interactive Brokers Group, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

IBKR

Interactive Brokers Group's Options: A Look at What the Big Money is Thinking

Press Releases

CORRECTION -- AmpliTech Group's 5G Division Receives Initial Order For Three Configurations Of The Company's Suite of 5G ORAN Radios

AmpliTech Group Announces Over $2.1M in New Purchase Orders in Q1, All Set for Delivery in Fiscal Year 2025

Legal

AmpliTech Group's Recently Issued Patents Valued at $14.9 Million by ipCapital Group

AmpliTech Group Announces Innovative True 5G Technology Development

Contracts

AmpliTech Group Announces Initial Order For Flagship ORAN 64T64R MIMO Radio

AmpliTech Group's 5G Division Enters Into An LOI For US$78 Million In Purchase Orders For AmpliTech's 5G ORAN Radios

AmpliTech Group Secures Major Milestone: Receives Initial Purchase Order from Leading 5G ORAN Player Marking Beginning Of US$78M Announced LOI

Earnings

AmpliTech Reports FY 2024 Financial Results

AmpliTech Group, Inc. Highlights "Made in the USA" Products Amidst Booming Industry Growth and Global Trade Tensions

AmpliTech Group's 5G Division Secures Company-Record Approx. US$11 Million Purchase Orders As Part Of A New Multi-Year LOI From Tier 1 North American MNO

Comments

AmpliTech Group

AmpliTech Group (AMPG) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌